PROGNOSIS
Early response to treatment predicts remission and recovery at 3 years in people with schizophrenia
| The first 150 words of the full text of this article appear below. |
What are the remission and recovery rates in people with schizophrenia, and what predicts these rates?
392 people (mean age 37.9 years, 50% male) with schizophrenia (DSM-IV), aged 18 years or older, who had never received antipsychotic treatment. Participants were moderately ill with a mean Clinical Global Impressions-Severity of Illness scale (CGI-Schizophrenia; CGI-SCH) score of 4.4, and had a short history of illness (median 0.6 years). Initial treatment was with atypical antipsychotics for 92% and with conventional antipsychotics for the remaining 8%.
Outpatient setting, Germany; recruitment January–December 2001.
Predictors at baseline: duration of illness, age, gender, symptomatic status (CGI-SCH); functional variables, quality of life/subjective wellbeing (Subjective Wellbeing under Neuroleptic Treatment Scale, SWN-K). Predictors in the early course of treatment: (first 3 months) subjective wellbeing, symptomatic remission and functional remission. Predictors during the course of treatment: substance use disorder (SUD) during follow-up (not present at baseline); remitted SUD (SUD at baseline
Department of Psychiatry, Faculty of Health Sciences, University of Stellenbosch, Cape Town, South Africa
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
